Advertisement

Activation of Sensory Nerves by Kinins: Pharmacologic Tools for Studying Kinin Receptors

  • D. Regoli
  • N.-E. Rhaleb
  • N. Rouissi
  • C. Tousignant
  • D. Jukic
  • C. Drapeau
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 298)

Abstract

Bradykinin and kallidin are released in blood and tissues by several stimuli and produce a variety of local effects by acting as autacoids. Some of these effects appear to be initiated by stimulation of afferent fibers and produce tissue responses of reflex nature. Indeed, bradykinin has been shown to be the most active endogenous agent to produce pain sensation when applied to blister base in man (1, 2, 3): this peptide has also been found to activate nociceptive responses in laboratory animals (Table 1), among others the writhing syndrome in the mouse (4, 5) the vocalization response in the dog (6), the reflex head flexion reaction in the rat (7, 8) and other painful responses (see Garcia-Leme (9) and Clark (50), for reviews). In other in vivo assays in the dog, the cat and the rat, bradykinin has been used to stimulate sensory fibers and activate cardiovascular reflexes. Thus, Lombardi et al. (10) and Malliani (11) have applied bradykinin in the coronary arteries of anesthetized cats to activate reflex responses of the sympathetic and vagal cardiac sensory nerves. They have observed an increase of the left ventricular and of the systemic pressures, together with a significant increase in the sympathetic efferent impulses.

Keywords

Rabbit Aorta Kinin Receptor Iris Sphincter Paracrine Hormone Vocalization Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D. Armstrong, Pain, in: “Handbook of Experimental Pharmacology, Vol. 25, Bradykinin, Kallidin and Kallikrein, E.G. Erdös, ed., Springer-Verlag, Berlin, pp.434–481 (1970).CrossRefGoogle Scholar
  2. 2.
    D.C. Manning, A.A. Khan, J.N. Campbell, R.A. Meyer and S.N. Raja, Bradykinin induced cutaneous pain is independent of wheal and flare, Pain (Suppl.) 4:S16 (abstr.) (1987).CrossRefGoogle Scholar
  3. 3.
    E.T. Whalley, S. Clegg, J.M. Stewart and R.J. Vavrek, The effect of kinin agonists and antagonists on the pain response of the human blister base, Naunyn Schmeideberg’s Arch. Pharmacol., 336:652 (1987)CrossRefGoogle Scholar
  4. 4.
    J.M. Emerle and J.E. Shanaman, Bradykinin writhing: a method for measuring analgesia, Pro. Soc. Exp. Biol. Med. 114:680 (1963).Google Scholar
  5. 5.
    L.R. Steranka, C.J. Detlaas, R.J. Vavrek, J.M. Stewart, S.J. Enna and S.H. Snyder, Antinociceptive effects of bradykinin antagonists, Eur. J. Pharmacol., 136:261 (1987).PubMedCrossRefGoogle Scholar
  6. 6.
    G.D. Potter, F. Guzman and R.K.S. Lim, Visceral pain evoked by intra-arterial injection of substance P, Nature, 193:983 (1962).PubMedCrossRefGoogle Scholar
  7. 7.
    G. Deffenu, L. Pegrassi and B. Lumachi, The use of bradykinin-induced effects in rats as an assay for analgesic drugs, J. Pharm. Pharmacol., 18:135 (1966).PubMedCrossRefGoogle Scholar
  8. 8.
    L.R. Steranka, D.C. Manning, C.J. DeHaas, J.W. Ferkany, S.A. Borosky, J.R. Connor, R.J. Vavrek, J.M. Stewart and S.H. Snyder, Bradykinin as a pain mediator: Receptors are localized to sensory neurons and antagonists have analgesic actions, Proc. Natl. Acad. Sci., 85:3245 (1988).PubMedCrossRefGoogle Scholar
  9. 9.
    J. Garcia-Leme, Bradykinin-System, in: “Handbook of Experimental Pharmacology”, Vol. 50/1, J.R. Vane, S.H. Ferreira, eds. Inflammation, Springer Verlag, Berlin (1978).Google Scholar
  10. 10.
    F. Lombardi, C.P. Patton, P.D. Bella, M. Pagani and A. Malliani, Cardiovascular and sympathetic responses reflexly elicited through the excitation with bradykinin of sympathetic and vagal cardiac sensory endings in the cat, Circulation Res., 57:65 (1982).Google Scholar
  11. 11.
    A. Malliani, Cardiovascular sympathetic afferent fibers, Rev. Physiol. Biochem. Pharmacol., 94:11 (1982).CrossRefGoogle Scholar
  12. 12.
    D.G. Baker, H.M. Coleridge, J.C.G. Coleridge and T. Nerdrum, Search for a cardiac nociceptor: stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat, J. Physiol. London, 306:519 (1980).PubMedGoogle Scholar
  13. 13.
    J. Staszewska-Barzak, S.H. Ferreira and J.R. Vane, An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia, Card. Res., 10:314 (1980)CrossRefGoogle Scholar
  14. 13.
    J. Staszewska-Barzak, S.H. Ferreira and J.R. Vane, An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia, Card. Res., 10:314 (1980)CrossRefGoogle Scholar
  15. 15.
    Y. Uchida and S. Murao, Bradykinin-induced excitation of afferent cardiac sympathetic nerve fibers, Jap. Heart J., 15:84 (1974).PubMedCrossRefGoogle Scholar
  16. 16.
    J.C. Longhurst, M.P. Kaufman, G.A. Ordway and T.J. Mush, Effects of capsaicin and bradykinin on endings of afferent fibers from abdominal visceral organs, Am. J. Physiol., 245:R552 (1984).Google Scholar
  17. 17.
    F. Rioux, H. Bachelard, S. St-Pierre and J. Barabé, Epicar-dial application of bradykinin elicits pressor effects and tachycardia in guinea-pigs, Possible mechanisms, Peptides, 8:863 (1987).PubMedCrossRefGoogle Scholar
  18. 18.
    P. Geppetti, C.A. Maggi, F. Perretti, S. Frilli and S. Manzini, Simultaneous release by bradykinin of substance P and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart, Br. J. Pharmacol., 94:288 (1988).PubMedCrossRefGoogle Scholar
  19. 19.
    M.P. Kaufman, H.M. Coleridge, J.C.G. Coleridge and D.G. Baker, Bradykinin stimulates afferent vagal C-fibres in intrapulmonary airways of dogs, J. Appl. Physiol., 48:511 (1980).PubMedGoogle Scholar
  20. 20.
    J.C.G. Coleridge and H.M. Coleridge, Afferent vagal C-fibre innervation of the lungs and airways and its functional significance, Rev. Physiol. Biochem. Pharmacol., 99:1 (1984).PubMedCrossRefGoogle Scholar
  21. 21.
    B.G. Simonsson, B.E. Skoogh, N.P. Bergh, R. Andersson and N. Svedmyr, In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airways obstruction, Respiration, 30:378 (1973).PubMedCrossRefGoogle Scholar
  22. 22.
    R.W. Fuller, C.M.S. Dixon, F.M.C. Cuss and P.I. Barnes, Bradykinin-induced bronchoconstriction in man: mode of action, Am. Rev. Respir. Dis., 135:176 (1987).PubMedGoogle Scholar
  23. 23.
    P.J. Barnes, Airway neuropeptides and asthma, TIPS, 8:24 (1987).Google Scholar
  24. 24.
    R.K.S. Lim, D.G. Miller, F. Guzman, D.W. Rodgers, R.W. Rogers, S.K. Wang, P.Y. Chao and T.Y. Shih, Pain and analgesia evaluated by the intraperitoneal bradykinin-evoked pain method in man, Clin. Pharmacol. Ther., 8:521 (1967).PubMedGoogle Scholar
  25. 25.
    A. Nasjletti and K.U. Malik, Relationships between the kal-likrein-kinin and prostaglandin systems, Life Sci., 25:99 (1979).PubMedCrossRefGoogle Scholar
  26. 26.
    D. Regoli, J. Barabé and W.K. Park, Receptors for bradykinin in rabbit aortae, Can. J. Physiol. Pharmacol., 55:855 (1977).PubMedCrossRefGoogle Scholar
  27. 27.
    D. Regoli, N.E. Rhaleb, S. Dion and G. Drapeau, Bradykinin receptors: B1 and B2 and what else? TIPS, in press (1990).Google Scholar
  28. 28.
    C.P. Sung, A.J. Arleth, K. Shikano and B.A. Berkowitz, Characterization and function of bradykinin receptors in vascular endothelial cells, J. Pharmacol. Exp. Ther., 247:8 (1988).PubMedGoogle Scholar
  29. 29.
    P. D’Orléans-Juste, G. de Nucci and J.R. Vane, Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells, Br. J. Pharmacol., 96:920 (1989).PubMedCrossRefGoogle Scholar
  30. 30.
    F. Marceau, A. Lussier, D. Regoli and J.-P. Giroud, Pharmacology of kinins: their relevance to tissue injury and inflammation, Gen. Pharmacol., 14:209 (1983).PubMedCrossRefGoogle Scholar
  31. 31.
    K.U. Malik and A. Nasjletti, Attenuation by bradykinin of adrenergically-induced vasoconstriction in the isolated perfused kidney of the rabbit: relationship to prostaglandin synthesis, Br. J. Pharmacol., 67:269 (1979).PubMedCrossRefGoogle Scholar
  32. 32.
    F. Lombardi, P.D. Bella, R. Casati and A. Malliani, Effects of intracoronary administration of bradykinin on the impulse activity of afferent sympathetic unmyelinated fibers with left ventricular endings in the cat, Circulation Res., 48:69 (1981).PubMedCrossRefGoogle Scholar
  33. 33.
    J. Barabé, F. Marceau, B. Thériault, J.-N. Drouin and D. Regoli, Cardiovascular actions of kinins in the rabbit, Can. J. Physiol. Pharmacol., 57:78 (1979.PubMedCrossRefGoogle Scholar
  34. 34.
    S.H. Ferreira and J.R. Vane, The disappearance of bradykinin and eledoisin in the circulation of vascular beds of the cat, Br. J. Pharmacol., 30:417 (1967).Google Scholar
  35. 35.
    G. Bönner, S. Preis, V. Shunk and D. Iwersen, Hemodynamic effects of kinins and their role in blood pressure regulation in “The Kallikrein-Kinin System in Health and Disease”, H. Fritz et al. eds., Limbach-Verlag, Braunschweig, Germany (1989).Google Scholar
  36. 36.
    O.A. Carretero and A.G. Scicli, Kinins paracrine hormone, in “The Kallikrein-Kinin System in Health and Disease”, H. Fritz et al. eds., Limbach-Verlag, Braunschweig, Germany (1989).Google Scholar
  37. 37.
    A. Dray and M.N. Perkins, Bradykinin activates peripheral capsaicin-sensitive fibres via a second messenger system, Agents and Actions, 25:214 (1988).PubMedCrossRefGoogle Scholar
  38. 38.
    P.M. Dunn and H.P. Rang, Bradykinin activation of primary afferent terminals in the neonate rat spinal cord in vitro, Br. J. Pharmacol., 98:827P (abs.)(1989).CrossRefGoogle Scholar
  39. 39.
    T. Kudo, H.L. Chang, M. Kuroi, S. Wakisaka, M. Akai and R. Inoki, Influences of bradykinin and substance P on the Metenkephalin-like peptide content in the rat incisor pulp, Neuropeptides, 7:399 (1986).PubMedCrossRefGoogle Scholar
  40. 40.
    C.A. Maggi, R. Patacchini, P. Santicioli, P. Geppetti, R. Cecconi, S. Giuliani and A. Meli, Multiple mechanisms in the motor response of the guinea-pig isolated urinary bladder to bradykinin, Br. J. Pharmacol., 98:619 (1989).PubMedCrossRefGoogle Scholar
  41. 41.
    T. Griesbacher and F. Lembeck, Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venocon-striction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit, Br. J. Pharmacol., 92:333 (1987).PubMedCrossRefGoogle Scholar
  42. 42.
    J.M. Butter and B. Hammond, Neurogenic responses of the eye injury: effect of sensory denervation on the responses of the rabbit eye to bradykinin and prostaglandin E1, Trans. Ophthalmol. Soc. U.K., 97:668 (1977).Google Scholar
  43. 43.
    H. Juan and F. Lembeck, Action of peptides and other algesic agents on paravascular pain receptor of the isolated perfused rabbit ear, Naunyn-Schmiedebergs Arch. Pharmacol. 283:151 (1974).PubMedCrossRefGoogle Scholar
  44. 44.
    T. Doi, A. Akaike, M. Ohashi, M. Satoh and H. Takaji, Bradykinin-induced flexor reflex of rabbit hindlimb for comparing analgesics, Jap. J. Pharmacol., 26:634 (1976).PubMedCrossRefGoogle Scholar
  45. 45.
    W.M. Yau, J.A. Dorsett and M.L. Youther, Bradykinin releases acetylcholine from myenteric plexus by a prostaglandin-mediated mechanism, Peptides, 7:289 (1986).PubMedCrossRefGoogle Scholar
  46. 46.
    O. Laneuville and R. Couture, Bradykinin analogue blocks bradykinin-induced inhibition of a spinal nociceptive reflex in the rat, Eur. J. Pharmacol., 137:281 (1987).PubMedCrossRefGoogle Scholar
  47. 47.
    T.N. Bhalla, S.N. Sinha, R.P. Kohli and K.P. Bhargava, A comparative study of the writhing response induced by phenylquinone, bradykinin and aconitine for the assessment of analgesic agents, Jap. J. Pharmacol., 23:609 (1973).PubMedCrossRefGoogle Scholar
  48. 48.
    S.H. Ferreira, S. Moncada and J.R. Vane, Potentiation by prostaglandins of the nociceptive activity of bradykinin in the dog knee joint, Br. J. Pharmacol., 50:461P (abst.)(1974).CrossRefGoogle Scholar
  49. 49.
    P. Devillier, M. Renoux, G. Drapeau and D. Regoli, Histamine release from rat peritoneal mast cells by kinin antagonists, Eur. J. Pharmacol., 149:137 (1988).PubMedCrossRefGoogle Scholar
  50. 50.
    W.C. Clark, Kinins and the peripheral and central nervous system, Handb. Exp. Pharmacol. 25 (suppl.):311 (1979).CrossRefGoogle Scholar
  51. 51.
    P. Devillier, G. Drapeau, M. Renoux and D. Regoli, Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides, Eur. J. Pharmacol., 168:53 (1989).PubMedCrossRefGoogle Scholar
  52. 52.
    N.E. Rhaleb, S. Télémaque, N. Rouissi, S. Dion, D. Jukic, G. Drapeau and D. Regoli, Structure-activity studies of bradykinin and related peptides. II. Antagonists., Br. J. Pharmacol., (submitted)(1990).Google Scholar
  53. 53.
    D. Regoli, G. Drapeau, P. Rovero, S. Dion, N.-E. Rhaleb, J. Barabé, P. D’Orléans-Juste and P. Ward, Conversion of kinins and their antagonists into B., receptor activators and blockers in isolated vessels, Eur. J. Pharmacol., 127:219 (1986).PubMedCrossRefGoogle Scholar
  54. 54.
    D. Regoli, N.-E. Rhaleb, G. Drapeau, S. Dion, C. Tousignant and P. D’Orléans-Juste, Basic pharmacology of kinins in: “Pharmacologic receptors and other mechanisms, Kinins V.,” Plenum Press, New York (1989).Google Scholar
  55. 55.
    D. Regoli, N.-E. Rhaleb, G. Drapeau, S. Dion, Kinin receptor subtypes, J. Cardiovasc. Pharmacol., (in press) (1990).Google Scholar
  56. 56.
    R.J. Vavrek and J.M. Stewart, Competitive antagonists of bradykinin, Peptides, 6:161 (1985).PubMedCrossRefGoogle Scholar
  57. 57.
    J.M. Stewart and R.J. Vavrek, Design of bradykinin antagonists in: Peptides, Chemistry and Biology. Proceedings of the Tenth American Peptide symposium, G.R. Marshall ed., Escom Leiden (1988).Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • D. Regoli
    • 1
  • N.-E. Rhaleb
    • 1
  • N. Rouissi
    • 1
  • C. Tousignant
    • 1
  • D. Jukic
    • 1
  • C. Drapeau
    • 1
  1. 1.Department of Pharmacology, Medical SchoolUniversity of SherbrookeSherbrookeCanada

Personalised recommendations